LPL Financial
AUPH icon

LPL Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

LPL Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.07M Sell
66,026
-6,588
-9% -$105K ﹤0.01% 4439
2026
Q2 		$1.23M Buy
72,614
+16,514
+29% +$264K ﹤0.01% 4232
2026
Q1 		$831K Sell
56,100
-8,426
-13% -$123K ﹤0.01% 4339
2025
Q4 		$1.03M Sell
64,526
-258,780
-80% -$3.67M ﹤0.01% 4050
2025
Q3 		$3.57M Buy
323,306
+262,295
+430% +$2.86M ﹤0.01% 2776
2025
Q2 		$517K Buy
61,011
+16,311
+36% +$131K ﹤0.01% 4362
2025
Q1 		$359K Sell
44,700
-1,900
-4% -$15.4K ﹤0.01% 4457
2024
Q4 		$418K Buy
46,600
+8,327
+22% +$67.9K ﹤0.01% 4248
2024
Q3 		$281K Buy
38,273
+2,091
+6% +$13K ﹤0.01% 4491
2024
Q2 		$207K Buy
36,182
+3,175
+10% +$16.7K ﹤0.01% 4545
2024
Q1 		$165K Sell
33,007
-210
-0.6% -$1.42K ﹤0.01% 4547
2023
Q4 		$299K Buy
33,217
+600
+2% +$4.94K ﹤0.01% 4090
2023
Q3 		$253K Buy
32,617
+2,900
+10% +$28.4K ﹤0.01% 4064
2023
Q2 		$288K Buy
29,717
+4,809
+19% +$49.9K ﹤0.01% 3885
2023
Q1 		$273K Sell
24,908
-431
-2% -$3.8K ﹤0.01% 3813
2022
Q4 		$109K Sell
25,339
-781
-3% -$4.53K ﹤0.01% 4144
2022
Q3 		$196K Sell
26,120
-423
-2% -$3.66K ﹤0.01% 3941
2022
Q2 		$267K Sell
26,543
-2,400
-8% -$26.8K ﹤0.01% 3724
2022
Q1 		$358K Buy
28,943
+3,060
+12% +$47.3K ﹤0.01% 3443
2021
Q4 		$592K Buy
25,883
+7,929
+44% +$188K ﹤0.01% 3129
2021
Q3 		$397K Sell
17,954
-4,036
-18% -$64K ﹤0.01% 3424
2021
Q2 		$285K Buy
21,990
+7,897
+56% +$101K ﹤0.01% 3625
2021
Q1 		$183K Buy
14,093
+1,190
+9% +$17.3K ﹤0.01% 3790
2020
Q4 		$178K Buy
+12,903
New +$188K ﹤0.01% 3561
2017
Q2 		– Sell
-30,002
Closed -$209K – 2805
2017
Q1 		$209K Buy
+30,002
New +$139K ﹤0.01% 2466

Other funds holding AUPH

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Hussman Strategic Advisors
Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

LPL Financial's AUPH Position: Q3 2026 in Review

LPL Financial reduced its Aurinia Pharmaceuticals (AUPH) stake by 9.1% in Q3 2026, selling an estimated $105K and leaving 66,026 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4439.

LPL Financial first reported a position in AUPH in Q1 2017 and has held it in 25 quarters since. The position peaked at $3.57M in Q3 2025. 102 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • LPL Financial held 66,026 shares of Aurinia Pharmaceuticals worth $1.07M as of Q3 2026.
  • LPL Financial sold 6,588 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $105K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4439 holding.
  • LPL Financial first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 25 quarters since.
  • LPL Financial's Aurinia Pharmaceuticals position peaked at $3.57M in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.